Formulations and methods for direct sodium removal in patients having heart failure and/or severe renal dysfunction
AssigneeDSRCo BV
InventorsJeffrey Testani, Christopher McIntyre, Ian Crosbie, Oliver Goedje
Life of this patent
Estimating the term…
Abstract
A direct sodium removal (“DSR”) infusate regimen and methods of use are provided for removing sodium and reducing fluid overload in patients with severe renal dysfunction and/or heart failure, in which a patient has at least a first DSR session with a first DSR infusate having no or low sodium that is instilled into a patient's peritoneal cavity for a first dwell period to cause sodium and excess fluid to migrate to the patient's peritoneal cavity, and thereafter, the patient may undergo conventional dialysis to rebalance the patient's fluid and sodium levels.
Claims23
A direct sodium removal (DSR) infusate, comprising:
- (a) a sodium concentration equal to or less than 35 meq/L;
- (b) 10 grams of dextrose per 100 mL of aqueous solution, and
- (c) 15 to 30 grams of icodextrin per 100 mL of aqueous solution.
Dependencies are inferred from the claim text.